Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How

In an era of Precision Medicine, it is vital to collect biological data within clinical trials and to integrate their analysis within the outcomes of the trial. The identification of genomic biomarkers that affect treatment response to smoking cessation treatment, both pharmacological and behavioral...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nicotine Tob Res
Päätekijät: Chen, Li-Shiun, Zawertailo, Laurie, Piasecki, Thomas M, Kaprio, Jaakko, Foreman, Marilyn, Elliott, Hannah R, David, Sean P, Bergen, Andrew W, Baurley, James W, Tyndale, Rachel F, Baker, Timothy B, Bierut, Laura J, Saccone, Nancy L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Reviews
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896450/
https://ncbi.nlm.nih.gov/pubmed/28498934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/ntx097
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia